Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.

Wu, Ruishan; Wu, Cailin; Zhu, Bingming; Li, Jin; Zhao, Wenzhong

Wu, Ruishan; Wu, Cailin; Zhu, Bingming; Li, Jin; Zhao, Wenzhong.

Afiliación

Wu R; NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, China.
Wu C; Department of Gynecology, The University of HongKong-Shenzhen Hospital, Shenzhen, China.
Zhu B; Department of Clinical Laboratory, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Li J; Department of Pain Management, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zhao W; NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, China.

Front Mol Biosci ; 10: 1192313, 2023.

Article en En | MEDLINE | ID: mdl-37363398

Palabras clave

RTN1; endometrial carcinoma (UCEC); polycystic ovary syndrome (PCOS); prognostic marker; tumor mutation burden

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Mol Biosci Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google